title: Hyskon-induced pulmonary edema.
abstract: Hyskon (32 percent dextran-70) (Hyskon Division, Pharmacia) is used during hysteroscopy to help visualization of the uterine surfaces. Pulmonary edema of an uncertain cause has occurred in many patients. Because this study could not be conducted in humans, we determined if Hyskon caused cardiogenic or non-cardiogenic pulmonary edema in a dog model. Dogs were randomly assigned to receive an infusion of Hyskon or whole blood to sustain left ventricular end-diastolic pressure between 20 and 23 millimeters of mercury for 60 minutes. In dogs receiving blood, there was no protein in the bronchoalveolar lavage before or after blood was given. In the Hyskon group, there was no protein in the bronchoalveolar lavage before Hyskon and 0.6 +/- 1.4 milligrams per deciliter (range of 0.1 to 3.7 milligram per deciliter) after Hyskon. The ratio of bronchoalveolar lavage protein to plasma protein after Hyskon was 8.0 +/- 18.0 percent compared with zero percent in the blood group. Hyskon altered pulmonary microvascular membrane permeability, causing alveolar flooding with plasma proteins and possibly accounting for the deterioration of oxygenation and pulmonary compliance seen in patients. These results suggest a significant noncardiogenic component of Hyskon induced pulmonary edema.
authors.affiliation: Department of Anesthesiology, University of South Florida College of Medicine, Tampa 33612.
authors.forename: D
authors.initials: D
authors.lastname: Mangar
mesh_terms: D000818:Animals; D001803:Blood Transfusion; D003911:Dextrans / Q000009:adverse effects*; D004285:Dogs; D005260:Female; D006439:Hemodynamics; D008297:Male; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D003911:Dextrans